Project
Zentavril in Heart Failure: Evidence & Education
Everything you need to know about Zentavril.
What is it about?
THIS PAGE IS DUMMY INFORMATION CREATED FOR DEMO PURPOSES. Some of the content on this page has been created using generative AI. Endovanta Therapeutics is a fictional biotech / pharma company. Zentavril is a fictional drug for heart failure.
Kudos customers use these 'story' pages to summarize and drive discoverability of medical publications, clinical information, and medical education content.
You can include a full clinical summary of the research, or a shorter piece designed to drive traffic to your own content hub. You can add links to any kind of outputs related to the drug development process. You can update these links throughout the process - for example, see the blue tile below ("REBALANCE-HF Trial Information") for how a page early in the development process might look, and then follow the "next step" links on each page to see how page might be updated throughout phases II and III. The page you are on here and now is an example of a page you might create post-launch to help drive discovery of your CME materials.
The Kudos data model is completely flexible. This demo is just showing suggestions for one way that you might use the platform to improve discoverability of medical publications and educational assets throughout your trial, and the different ways you might structure your content to guide audiences on curated pathways through your content. You could just as easily create a suite of interconnected pages to curate information for a specific region; you could focus on a particular molecule - or, more broadly, on an entire therapy area - rather than on one specific drug; and so on.
Why is it important?
These two boxes would usually be used to structure your summary into "what it is about" and "why it is important". Clients then add links to the outputs for which they are trying to drive discovery -- see how these look in the grey area below. They can all be labelled to give audiences an indication of the types of content available to them.
More typical content on a page like this would be: This page offers medical education materials to support healthcare professionals in understanding and prescribing Zentavril. Content includes real-world evidence, case studies, guidance on patient selection, and continuing education resources.
Ongoing education ensures that clinicians have up-to-date knowledge on how to use Zentavril safely and effectively. This supports optimal patient outcomes and helps integrate new therapies into clinical practice responsibly.
Want to continue the demo? Click on the blue tile below ("REBALANCE-HF Trial Information") for how a page early in the development process might look, and then follow the "next step" links on each page to see how page might be updated throughout phases II and III.
Seen enough? Contact our team (sarah.mustapha@growkudos.com) for an online demo where she can also show you the metrics that sit behind these pages, and how we help you see which formats are driving discoverability, which pathways audiences prefer for navigating your content, how this corresponds to citations, and much more.
